RWLK - JAGX TELL CRDF and DTIL among premarkets gainers

Vinco Ventures (BBIG) +265%.Genetic Technologies (GENE) +79% as COVID-19 risk test further enhances predictive capabilities.Celsion (CLSN) +65%.Addex Therapeutics (ADXN) +64% as ADX71149 receives IND approval to start a phase 2a clinical study in Epilepsy.INmune Bio (INMB) +39% after positive XPro1595 data in Alzheimer’s trial.Qutoutiao (QTT) +32%.Tengasco (TGC) +30%.Profire Energy (PFIE) +29%.Medley Management (MDLY) +25% after the company discloses insiders' stakes and change in their beneficial ownerships.Precision BioSciences (DTIL) +17%.electroCore (ECOR) +17% as Scottish Health Technology recommends use of gammaCore™.Barnwell Industries (BRN) +17%.Jaguar Health (JAGX) +16%.BioHiTech Global (BHTG) +16%.Iterum Therapeutics (ITRM) +15%.TuanChe (TC) +15% on CEO's going private proposal at $4.25/ADS.Tellurian (TELL) +14%.Motus GI Holdings (MOTS) +13%.ADiTx Therapeutics (ADTX) +13% after announcing launch of the AditxtScore™ Immune Monitoring Platform.OncoCyte Corporation (OCX) +10% on $25M registered offering.Lipocine (LPCN) +10%.Cardiff Oncology (CRDF) +10%.FinServ Acquisition (FSRV) +10%.ReWalk Robotics (RWLK) +9%.Torchlight Energy Resources (TRCH) +9% as Masterson notified the Company to exercise its option to perform operations, at Masterson's sole cost and expense, on

For further details see:

JAGX, TELL, CRDF and DTIL among premarkets gainers